Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Immune Protocol

GramicidinComplete Dosing & Administration Guide

Historic 15-amino-acid linear pentadecapeptide antibiotic with alternating D- and L-amino acids — the first commercially produced antibiotic discovered by René Dubos in 1939, forming monovalent cation-selective transmembrane channels in bacterial membranes, FDA-approved as a topical/ophthalmic antimicrobial component of Neosporin and related preparations

Dose Range

0.025-0.25mg/mL

Frequency

Multiple times daily

Route

Topical application (primary clinical route)

Cycle Length

8-12 weeks

Dosing

How much
do I take?

Starting Dose

Ophthalmic: 0.025 mg/mL (1-2 drops) or thin layer of ointment

Frequency

Two to three times daily

Duration

3-5 days initial assessment

Standard ophthalmic dosing for mild bacterial conjunctivitis. Apply 1-2 drops of gramicidin-containing ophthalmic solution (Neosporin Ophthalmic: gramicidin 0.025 mg/mL + neomycin 1.75 mg/mL + polymyxin B 10,000 units/mL) to the affected eye. Or apply thin ribbon of ophthalmic ointment to the lower conjunctival sac. Topical skin use: apply thin layer of triple antibiotic ointment to clean wound.

Standard Dose

Ophthalmic: 0.025 mg/mL (1-2 drops); Topical: thin layer of ointment

Frequency

Three to four times daily (ophthalmic); two to three times daily (topical)

Duration

7-10 days

Standard treatment course for bacterial conjunctivitis and moderate superficial infections. Ophthalmic: apply every 4-6 hours while awake. For topical wound care: clean wound, apply thin layer of gramicidin-containing antibiotic ointment, cover with sterile bandage. Do not use for longer than 10 days without medical reassessment. Available over-the-counter in most topical antibiotic preparations.

Advanced Dose

Research use: 1-50 µg/mL in electrophysiology or antimicrobial assays

Frequency

Protocol-dependent

Duration

Protocol-dependent

Research applications for ion channel biophysics, single-channel electrophysiology, antimicrobial susceptibility testing, or anticancer activity evaluation. Gramicidin is dissolved in methanol, ethanol, or DMSO stock solutions (typically 1-10 mg/mL) and diluted to working concentrations. For planar lipid bilayer experiments, picomolar to nanomolar concentrations are sufficient for single-channel recordings. For anticancer research, working concentrations of 1-50 µg/mL.

Timing

Best time to take

Apply Gramicidin to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.

With food?

As a topical product, Gramicidin is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.

If stacking

Gramicidin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Gramicidin in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Example

Gramicidin comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Gramicidin exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Gramicidin is administered Topical application (primary clinical route)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Technique

  • 1.Follow the specific administration instructions for your Gramicidin formulation
  • 2.Take or apply as directed by your healthcare provider
  • 3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Gramicidin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Gramicidin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (multiple times daily)

As prescribed by your healthcare provider injection

Site: Topical application (primary clinical route)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Gramicidin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Gramicidin is a cyclic peptide antibiotic derived from Bacillus brevis with a 70+ year track record of topical safety. It functions as a pore-former in bacterial membranes and shows minimal systemic absorption when applied to intact skin or mucous membranes, making it extremely low-toxicity for localized use. The primary safety concern is sensitization reactions in 1-5% of users with prolonged exposure, not organ toxicity. Gramicidin is FDA-approved for topical antibacterial applications and generally well-tolerated across age groups.

Gramicidin safety derives from extensive clinical use since 1940s as a topical antibiotic in wound care and oral preparations, with minimal adverse event reporting. In vitro studies confirm rapid bacterial cell death via ion channel disruption without mammalian toxicity at therapeutic concentrations. Contact dermatitis and allergic sensitization are the documented safety signals, not systemic toxicity. FDA oversight and decades of post-marketing surveillance support its continued use in medical devices and antimicrobial formulations.

Common Side Effects

Experienced by some users

Ophthalmic stinging/burning

Mild stinging or burning sensation upon instillation of ophthalmic drops, lasting 1-2 minutes. Common with most antibiotic eye drops.

Management: Self-limiting. Keep eyes closed for 1-2 minutes after application. If persistent, discontinue and consult ophthalmologist.

Local skin irritation

Mild redness or warmth at the topical application site. Common with antibiotic ointments and usually minor.

Management: Apply thin layer only. If irritation worsens, discontinue and try alternative topical antibiotic.

Temporary blurred vision

Brief visual blurring after application of ophthalmic ointment due to the ointment base coating the eye surface.

Management: Expected with ointment formulations. Vision clears within 5-10 minutes. Use drops instead of ointment during daytime if vision clarity is important.

Contact sensitization

Allergic contact dermatitis may develop with prolonged or repeated topical use, manifesting as increased redness, itching, or vesicle formation at the application site.

Management: Discontinue gramicidin-containing products. Topical corticosteroid for acute dermatitis. Patch testing may identify specific allergen if multiple antibiotic sensitivities.

Less Common

  • Superinfection

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Gramicidin
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Gramicidin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Systemic administration of any kind — gramicidin is strictly for topical and ophthalmic use due to hemolytic toxicity - Use with caution—discuss with your healthcare provider.
  • !Application to extensive burn wounds or large denuded skin areas — risk of systemic absorption and hemolysis - Use with caution—discuss with your healthcare provider.
  • !Contact lens wear during ophthalmic treatment — remove lenses before applying gramicidin ophthalmic preparations - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Gramicidin. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Gramicidin research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Gramicidin Profile

Medical Disclaimer

Gramicidin is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026